These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7193975)

  • 41. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
    Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
    Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacokinetics of cis-platinum diammine dichloride].
    Sawada M; Okudaira Y; Matsui Y; Nishiura H; Yanagida T
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):55-65. PubMed ID: 6892192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.
    Zivanovic O; Abramian A; Kullmann M; Fuhrmann C; Coch C; Hoeller T; Ruehs H; Keyver-Paik MD; Rudlowski C; Weber S; Kiefer N; Poelcher ML; Thiesler T; Rostamzadeh B; Mallmann M; Schaefer N; Permantier M; Latten S; Kalff J; Thomale J; Jaehde U; Kuhn WC
    Int J Cancer; 2015 Feb; 136(3):699-708. PubMed ID: 24895230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors.
    Pedram B; Moghadam AT; Kamyabi-Moghaddam Z; Mavedati O; Beigi BA; Sharabiyani AK; Dezfuli AB; Khalili S; Bahrami AM; Nasoori A
    Tumour Biol; 2015 Jun; 36(6):4495-500. PubMed ID: 25596088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in the toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration.
    Litterst CL
    Toxicol Appl Pharmacol; 1981 Oct; 61(1):99-108. PubMed ID: 7197408
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacokinetics of adriamycin and cisplatin for anhepatic chemotherapy during liver transplantation.
    Ku Y; Kusunoki N; Kitagawa T; Maeda I; Fukumoto T; Iwasaki T; Tominaga M; Suzuki Y; Kuroda Y; Tanigawara Y; Saitoh Y
    Cancer Chemother Pharmacol; 1997; 40(6):457-62. PubMed ID: 9332458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis.
    Frick GA; Ballentine R; Driever CW; Kramer WG
    Cancer Treat Rep; 1979 Jan; 63(1):13-6. PubMed ID: 421230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical pharmacokinetics of carboplatin.
    van der Vijgh WJ
    Clin Pharmacokinet; 1991 Oct; 21(4):242-61. PubMed ID: 1760899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.
    Casper ES; Kelsen DP; Alcock NW; Lewis JL
    Cancer Treat Rep; 1983 Mar; 67(3):235-8. PubMed ID: 6682012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic evidence for an enterohepatic circulation in a patient treated with cis-dichlorodiammineplatinum (II).
    Vermorken JB; van der Vijgh WJ; Pinedo HM
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):319-28. PubMed ID: 7190316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Whole-body autoradiographic study of the distribution of 195mPt in healthy and tumor-bearing mice treated with labeled cisplatin.
    Bénard P; Desplanches G; Macquet JP; Simon J
    Cancer Treat Rep; 1983 May; 67(5):457-66. PubMed ID: 6406060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion.
    Cano JP; Catalin J; Rigault JP; Bues-Charbit M; Placidi M; Raybaud C; Bernard JL
    Biomedicine; 1981 Dec; 34(3):146-53. PubMed ID: 7199945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.
    Piel IJ; Perlia CP
    Cancer Chemother Rep; 1975; 59(5):995-9. PubMed ID: 1106849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.
    Rahman A; Roh JK; Wolpert-DeFilippes MK; Goldin A; Venditti JM; Woolley PV
    Cancer Res; 1988 Apr; 48(7):1745-52. PubMed ID: 3162402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacokinetics of cisplatin and the effect of sodium thiosulfate].
    Hayata S; Hitoshi T; Kiyokawa K; Esaki S; Mihashi S; Hirano M
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2356-61. PubMed ID: 6541891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. cis-Dichlorodiammineplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer.
    Wittes R; Heller K; Randolph V; Howard J; Vallejo A; Farr H; Harrold C; Gerold F; Shah J; Spiro R; Strong E
    Cancer Treat Rep; 1979; 63(9-10):1533-8. PubMed ID: 498153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.
    Hanigan MH; Gallagher BC; Taylor PT; Large MK
    Cancer Res; 1994 Nov; 54(22):5925-9. PubMed ID: 7954424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
    Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.
    Fahmi AN; Shehatou GS; Shebl AM; Salem HA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):819-30. PubMed ID: 27215580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute and chronic cisplatin nephropathy in rats.
    Choie DD; Longnecker DS; del Campo AA
    Lab Invest; 1981 May; 44(5):397-402. PubMed ID: 7194946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.